Evidence map›Paper›PMID 36725865›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2023

Controlled human drug administration studies are necessary to define the THC-sparing effects of CBD and other cannabis constituents.

Elisa Pabon, Ziva D Cooper

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Elisa PabonUCLA Center for Cannabis and Cannabinoids, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Ziva D CooperUCLA Center for Cannabis and Cannabinoids, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. zcooper@mednet.ucla.edu.ORCID 0000-0001-8001-2332

Funding

Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and ß-caryophylleneR01AT010762 · NCCIH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI COOPER, ZIVA D · 2020 to 2025
$4.0M
Sex-dependent effects of cannabis: Assessing abuse-related and pharmacokinetic differences between men and womenR01DA047296 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI COOPER, ZIVA D · 2019 to 2024
$3.5M
The Next Generation Substance Abuse Research Training at Charles R. Drew University (CDU) and UCLA (NGSART-CU)R25DA050723 · NIDA · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI FRIEDMAN, THEODORE C · 2020 to 2024
$1.4M
NCCIH NIH HHS R01 AT010762NIDA NIH HHS R01 DA047296NIDA NIH HHS R25 DA050723
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabidiolCannabisHallucinogensCannabinoid Receptor AgonistsDronabinolHumansCannabidiolCannabinoid Receptor AgonistsDronabinolHallucinogens

Identifiers

PMID36725865
PMCPMC10156753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.